19-11007951-T-C
Variant summary
Our verdict is Likely benign. The variant received -3 ACMG points: 0P and 3B. BP4_ModerateBP6
The NM_001387283.1(SMARCA4):c.2051T>C(p.Val684Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000479 in 1,461,420 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. V684M) has been classified as Uncertain significance.
Frequency
Consequence
NM_001387283.1 missense
Scores
Clinical Significance
Conservation
Publications
- Coffin-Siris syndromeInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet, Illumina
- intellectual disability, autosomal dominant 16Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics
- rhabdoid tumor predisposition syndrome 2Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, ClinGen, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), G2P
- uterine corpus sarcomaInheritance: AR Classification: MODERATE Submitted by: Genomics England PanelApp
- familial rhabdoid tumorInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- hereditary nonpolyposis colon cancerInheritance: AD Classification: LIMITED Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -3 ACMG points.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| SMARCA4 | ENST00000646693.2 | c.2051T>C | p.Val684Ala | missense_variant | Exon 14 of 36 | NM_001387283.1 | ENSP00000495368.1 | |||
| SMARCA4 | ENST00000344626.10 | c.2051T>C | p.Val684Ala | missense_variant | Exon 14 of 35 | 1 | NM_003072.5 | ENSP00000343896.4 | ||
| SMARCA4 | ENST00000643549.1 | c.2051T>C | p.Val684Ala | missense_variant | Exon 14 of 35 | ENSP00000493975.1 | ||||
| SMARCA4 | ENST00000541122.6 | c.2051T>C | p.Val684Ala | missense_variant | Exon 15 of 35 | 5 | ENSP00000445036.2 | |||
| SMARCA4 | ENST00000643296.1 | c.2051T>C | p.Val684Ala | missense_variant | Exon 14 of 34 | ENSP00000496635.1 | ||||
| SMARCA4 | ENST00000644737.1 | c.2051T>C | p.Val684Ala | missense_variant | Exon 14 of 34 | ENSP00000495548.1 | ||||
| SMARCA4 | ENST00000589677.5 | c.2051T>C | p.Val684Ala | missense_variant | Exon 15 of 35 | 5 | ENSP00000464778.1 | |||
| SMARCA4 | ENST00000643995.1 | c.1463T>C | p.Val488Ala | missense_variant | Exon 11 of 32 | ENSP00000496004.1 | ||||
| SMARCA4 | ENST00000644963.1 | c.695T>C | p.Val232Ala | missense_variant | Exon 7 of 28 | ENSP00000495599.1 | ||||
| SMARCA4 | ENST00000644065.1 | c.776T>C | p.Val259Ala | missense_variant | Exon 7 of 27 | ENSP00000493615.1 | ||||
| SMARCA4 | ENST00000642350.1 | c.536T>C | p.Val179Ala | missense_variant | Exon 6 of 27 | ENSP00000495355.1 | ||||
| SMARCA4 | ENST00000643857.1 | c.404T>C | p.Val135Ala | missense_variant | Exon 5 of 25 | ENSP00000494159.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome AF: 0.00000479 AC: 7AN: 1461420Hom.: 0 Cov.: 31 AF XY: 0.00000550 AC XY: 4AN XY: 727022 show subpopulations
Age Distribution
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Intellectual disability, autosomal dominant 16 Uncertain:1
Rhabdoid tumor predisposition syndrome 2 Uncertain:1
This sequence change replaces valine, which is neutral and non-polar, with alanine, which is neutral and non-polar, at codon 684 of the SMARCA4 protein (p.Val684Ala). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with SMARCA4-related conditions. ClinVar contains an entry for this variant (Variation ID: 470277). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
Hereditary cancer-predisposing syndrome Benign:1
This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at